Modular Medical Inks National PBM Deal for Pivot Insulin Pump
MODD has more than doubled off its 52-week low of $1.72.
Summary
Modular Medical signed a contract with a national U.S. pharmacy benefit manager, making its Pivot tubeless patch pump available through that PBM's network. This is a major commercialization milestone for a company with a market cap under $30 million and a going-concern warning. The deal validates the product and expands patient access, potentially accelerating revenue. Shares rose 9% on the news. The company began initial commercialization in five markets in October 2026 and partnered with Inizio for launch support. Watch for further PBM contracts and initial sales data.
At the time of this announcement, MODD was trading at $3.62 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $29.5M. The 52-week trading range was $1.72 to $30.00. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Benzinga.